References:
1. Bongomin F et al. J Fungi (Basel). 2017;3(4):57.
2. Verweji PE et al. Intensive Care Med. 2020;46(8):1524–1535.
3. Crum-Cianflone NF. Open Forum Infect Dis. 2016;3(3):ofw171.
4. Gangneux JP et al. Journal de Mycologie Médicale. 2020;30(2):100971.
5. Taccone FS et al. Crit Care. 2015;19(1):7.
6. AmBisome® Summary of Product Characteristics (UK). Available at:
https://www.medicines.org.uk/emc/product/1022/smpc#gref. [Last accessed:
March 2023].
7. Prakash H and Chakrabarti A. Microorganisms. 2021;9(3):523.
8. Diwaker J et al. Med Mycol J. 2021;31(4):101203.
9. Nett JE and Andes DR. Infect Dis Clin North Am. 2016;30:51–83.
10. Lass-Flörl C et al. Antimicrob Agents Chemother. 2008;52(10):3637–3641.
11. Sanglard D and Coste AT. Antimicrob Agents Chemother.
2015;60(1):229–238.
12. Chamilos G et al. Clin Infect Dis. 2008;47(4):503–509.
13. Kumar A and Gupta V. Rhino-orbital Cerebral Mucormycosis.
[Updated 2022 Apr 28]. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2022 Jan. Available online
at: https://www.ncbi.nlm.nih.gov/books/NBK557429/#_NBK557429_
pubdet_. [Last accessed March 2023].
14. Skiada A et al. Med Mycol. 2018;56(Suppl.1):S93–S101.
15. Ilharco M et al. IDCases. 2019;18:e00591.
References:
1. Bongomin F et al. J Fungi (Basel). 2017;3(4):57.
14. Skiada A et al. Med Mycol. 2018;56(Suppl.1):S93–S101.
15. Ilharco M et al. IDCases. 2019;18:e00591.
2. Verweji PE et al. Intensive Care Med. 2020;46(8):1524–1535.
3. Crum-Cianflone NF. Open Forum Infect Dis. 2016;3(3):ofw171.
4. Gangneux JP et al. Journal de Mycologie Médicale. 2020;30(2):100971.
5. Taccone FS et al. Crit Care. 2015;19(1):7.
6. AmBisome® Summary of Product Characteristics (UK). Available at:
https://www.medicines.org.uk/emc/product/1022/smpc#gref. [Last accessed: March 2023].
7. Prakash H and Chakrabarti A. Microorganisms. 2021;9(3):523.
8. Diwaker J et al. Med Mycol J. 2021;31(4):101203.
9. Nett JE and Andes DR. Infect Dis Clin North Am. 2016;30:51–83.
10. Lass-Flörl C et al. Antimicrob Agents Chemother. 2008;52(10):3637–3641.
11. Sanglard D and Coste AT. Antimicrob Agents Chemother. 2015;60(1):229–238.
12. Chamilos G et al. Clin Infect Dis. 2008;47(4):503–509.
13. Kumar A and Gupta V. Rhino-orbital Cerebral Mucormycosis. [Updated 2022 Apr 28].
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Available online
at: https://www.ncbi.nlm.nih.gov/books/NBK557429/#_NBK557429_pubdet_. [Last accessed March 2023].
This educational tool is developed and fully funded by Gilead Sciences, and it is intended for healthcare
professionals only. It contains information about Gilead products, educational materials on therapy areas,
and professional resources.
Prescribing information for Liposomal Amphotericin B